X

XBiotech
D

XBIT

6.86000
USD
-0.20
(-2.83%)
Market Closed
Volume
0
EPS
0
Div Yield
-
P/E
-6
Market Cap
209,116,680
News

Title: XBiotech

Sector: Healthcare
Industry: Biotechnology
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.